Every material Form 8-K Axalta filed with the SEC in 2025, read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). Newest first; each brief links to its own page and to the filing on SEC.gov.
Axalta approved cash retention bonuses for certain employees, including three named executive officers, in connection with its pending all-stock merger with AkzoNobel announced November 18, 2025. The bonuses vest six months after the merger closes, subject to continued employment, so they are designed to keep key executives through the transaction.
CFO Carl D. Anderson II's retention bonus is $1,360,009, approved December 15, 2025
Hadi H. Awada (President, Global Mobility Coatings) has a bonus of $1,040,130
Troy D. Weaver (President, Global Refinish) has a bonus of $1,084,837; bonuses vest six months after the merger closing date
Axalta and AkzoNobel agreed on November 18, 2025 to combine in an all-stock merger of equals, creating a company with an enterprise value of approximately $25 billion. Each Axalta common share would convert into 0.6539 AkzoNobel ordinary shares, and Axalta shareholders would own 45% of the combined company after closing. The deal requires shareholder and regulatory approvals, is expected to close in late 2026 to early 2027, and both companies have suspended their share buyback programs.
Each Axalta common share would receive 0.6539 AkzoNobel ordinary shares.
Axalta shareholders would own 45% and AkzoNobel shareholders 55% of the combined company on a pro forma basis.
The companies expect approximately $600 million in run-rate cost synergies, with 90% achieved within three years after closing.
Closing is expected in late 2026 to early 2027; both companies suspended share buybacks effective immediately.
Axalta reported third-quarter 2025 results with net sales down 2% to $1.3 billion, while net income rose to $110 million and diluted EPS increased 11% to $0.51. The company also plans to deploy up to $250 million on share repurchases in the fourth quarter and amended its credit agreement to allow borrowings to fund those buybacks.
Q3 net sales fell 2% year over year to $1.3 billion, mainly on lower Performance Coatings sales in North America.
Q3 net income was $110 million, up $8 million year over year; diluted EPS was $0.51 versus $0.46.
Adjusted EBITDA was $294 million, a quarterly record, with margin of 22.8%.
Axalta plans up to $250 million of share repurchases in Q4 2025; Amendment No. 17, dated October 28, 2025, permits credit agreement borrowings to fund buybacks.
Axalta reported second-quarter 2025 results for the period ended June 30, 2025. Net sales fell 3% to $1.3 billion and net income fell 3% to $110 million, largely due to restructuring costs, while adjusted diluted EPS rose 5% to $0.64 and adjusted EBITDA reached a record $292 million. The company also issued third-quarter and updated full-year 2025 outlook figures, including full-year adjusted diluted EPS of $2.45 to $2.55.
Net sales were $1.3 billion, down 3% year over year, with volume declines mainly in Performance Coatings.
Diluted EPS was $0.50 versus $0.51 a year earlier; adjusted diluted EPS was $0.64, up 5%.
Adjusted EBITDA was a record $292 million, with a 22.4% margin, up 90 basis points.
Full-year 2025 outlook: adjusted EBITDA of $1,140 million to $1,165 million and adjusted diluted EPS of $2.45 to $2.55.
Axalta reported first quarter 2025 net sales of $1.26 billion, down 3% year over year, while net income rose 154% to $99 million. The profit gain was largely due to $55 million of prior-year expenses tied to its 2024 Transformation Initiative, and adjusted diluted EPS rose 16% to $0.59. The company also issued second quarter and full year 2025 outlook ranges, including full year adjusted EBITDA of $1,150 million to $1,175 million.
Net sales were $1.26 billion, down 3%, with a 3% foreign currency headwind; volume declines were primarily in Performance Coatings.
Diluted EPS rose to $0.45 from $0.18; adjusted diluted EPS rose 16% to $0.59.
Adjusted EBITDA was a first quarter record of $270 million, up 4%, with a margin of 21.4%.
Free cash flow was negative $14 million, compared with $15 million in the prior year period; operating cash flow was $26 million.
Axalta reported record fourth-quarter 2024 net sales of $1.3 billion, up 1%, and net income of $137 million, up 85% from a year earlier, helped by a $27 million deferred tax benefit. For the full year, net income rose to $391 million and Adjusted EBITDA reached $1,116 million, and the company gave 2025 guidance of $1,150 million to $1,175 million in Adjusted EBITDA and $2.50 to $2.60 in Adjusted Diluted EPS.
Q4 2024 diluted EPS was $0.63 versus $0.33 a year earlier; Adjusted Diluted EPS was $0.60, up 30%
Full-year 2024 net sales were $5.3 billion, up 2%, with net income of $391 million versus $269 million in 2023
Full-year 2025 guidance: Adjusted EBITDA of $1,150 million to $1,175 million and Adjusted Diluted EPS of $2.50 to $2.60
Q4 2024 free cash flow was $177 million, down from $254 million a year earlier, due to higher working capital and capital expenditures
Briefs are written by AI from the filing text (each brief's own page names the model) and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the model's reading of the filing for shareholders, not a price forecast. Not investment advice.
Only material 8-Ks get a brief: results, deals, executive changes, restructuring, impairments, delisting notices, restatements, cybersecurity incidents and other disclosed events. Routine filings (vote results, exhibits only) are skipped. Every Axalta filing is on SEC EDGAR ↗. 8-K briefs of other companies →